By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Announces New Clinical Trial Of Hema Diagnostic Systems’ Rapid 1-2-3 Tuberculosis Point-Of-Care Tests 9/20/2017 8:30:05 AM
Generex Biotechnology Corporation (GNBT) Provides Summary Of Ii-Key Hybrid Vaccine Platform 8/7/2017 9:03:58 AM
Generex Biotechnology Corporation (GNBT) Announces Collaboration With Merck & Co. (MRK) To Evaluate KEYTRUDA (Pembrolizumab) In Combination With AE37 In Patients With Triple-Negative Breast Cancer 7/31/2017 11:39:41 AM
Generex Biotechnology Corporation (GNBT) Announces $115M Convertible Preferred Stock Financing; First Tranche Satisfies Emmaus Deposit 3/29/2017 7:29:49 AM
Generex Biotechnology Corporation (GNBT) Announces Featured Presentation Of Cancer Immunotherapy Developed By Subsidiary At OPT Boston 3/27/2017 7:31:13 AM
Generex Biotechnology Corporation (GNBT) Announces Reverse Stock Split 3/14/2017 7:29:19 AM
Generex Biotechnology Corporation (GNBT) Provides Access Information For Investor Conference Call Scheduled For February 22, 2017 2/21/2017 8:40:13 AM
Generex Biotechnology Corporation (GNBT) Announces Elimination Of Outstanding Derivative Securities 2/15/2017 8:02:48 AM
Generex Biotechnology Corporation (GNBT) Provides Update On Deal To Acquire Controlling Equity Interest In Emmaus Life Sciences 2/9/2017 7:51:55 AM
Generex Biotechnology Corporation (GNBT) Welcomes Dr. Yutaka Niihara, M.D., M.P.H. To Its Board Of Directors 1/26/2017 10:59:12 AM
12345678910...
//-->